World News: 19:00 GMT Monday 16th April 2018. [Adaptimmune Therapeutics plc via Globe Newswire via SPi World News]
PHILADELPHIA Pa and OXFORD United Kingdom, April 16 2018 GLOBE NEWSWIRE -- Adaptimmune Therapeutics plcNasdaqADAP a leader in T-cell therapy to treat cancer presented two posters summarizing preclinical research with its MAGE-A4 and M AGE-A10...
Globe Newswire: 19:00 GMT Monday 16th April 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.